CLEVELAND BIOLABS INC - COM NEW (CBLI)

CUSIP: 185860202

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM NEW
Total 13F shares
622,517
Share change
+277,852
Total reported value
$2,147,035
Price per share
$3.45
Number of holders
15
Value change
+$998,830
Number of buys
5
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 185860202?
CUSIP 185860202 identifies CBLI - CLEVELAND BIOLABS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CLEVELAND BIOLABS INC - COM NEW (CBLI) as of Q4 2020

As of 31 Dec 2020, CLEVELAND BIOLABS INC - COM NEW (CBLI) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 622,517 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, PNC Financial Services Group, Inc., CITADEL ADVISORS LLC, BARCLAYS PLC, MORGAN STANLEY, and UBS Group AG. This page lists 15 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.